Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The ongoing importance of smoking as a powerful risk factor for ST-segment elevation myocardial infarction in young patients.

Larsen GK, Seth M, Gurm HS.

JAMA Intern Med. 2013 Jul 8;173(13):1261-2. doi: 10.1001/jamainternmed.2013.6075. No abstract available.

PMID:
23712862
2.

Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.

Lin GM, Li YH.

Am J Cardiol. 2011 Feb 15;107(4):641. doi: 10.1016/j.amjcard.2010.11.001. No abstract available.

PMID:
21295179
3.
4.

Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry.

McCabe JM, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, Patel A, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P.

Arch Intern Med. 2012 Jun 11;172(11):864-71. doi: 10.1001/archinternmed.2012.945.

PMID:
22566489
5.

[Management of ST-elevation myocardial infarction in 2012].

Cayla G, Silvain J, Ecollan P, Montalescot G, Collet JP.

Ann Cardiol Angeiol (Paris). 2012 Dec;61(6):447-52. doi: 10.1016/j.ancard.2012.09.016. Epub 2012 Oct 4. French.

PMID:
23078947
6.

[Care of ST elevated myocardial infarction patients in Vendée in 2008: observational and descriptive study].

Trebouet E, Fradin P, Orion L, Dimet J.

Ann Cardiol Angeiol (Paris). 2010 Aug;59(4):209-13. doi: 10.1016/j.ancard.2010.06.003. Epub 2010 Jul 23. French.

PMID:
20674885
7.

Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.

Maeng M, Nielsen PH, Busk M, Mortensen LS, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators.

Am J Cardiol. 2010 Jun 1;105(11):1528-34. doi: 10.1016/j.amjcard.2010.01.005. Epub 2010 Apr 14.

PMID:
20494656
8.

Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry.

McCabe JM, Armstrong EJ, Hoffmayer KS, Bhave PD, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):672-9. Epub 2012 Sep 4.

9.

[Epidemiological observations on survival in the first year after acute ST-elevation myocardial infarction (STEMI) treated by primary angioplasty].

Deak E, Brumboiu MI, Tigan S, Bocşan IS.

Rev Med Chir Soc Med Nat Iasi. 2011 Jul-Sep;115(3):905-13. Romanian.

PMID:
22046807
10.

Impact of pre-procedural beta blockade on inpatient mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.

Valle JA, Zhang M, Dixon S, Aronow HD, Share D, Naoum JB, Gurm HS.

Am J Cardiol. 2013 Jun 15;111(12):1714-20. doi: 10.1016/j.amjcard.2013.02.022. Epub 2013 Mar 22.

PMID:
23528025
11.

Comparison of hospital mortality during ST-segment elevation myocardial infarction in the era of reperfusion therapy in women versus men and in older versus younger patients.

Juliard JM, Golmard JL, Himbert D, Feldman LJ, Delorme L, Ducrocq G, Descoutures F, Sorbets E, Garbarz E, Boudvillain O, Aubry P, Vahanian A, Steg PG.

Am J Cardiol. 2013 Jun 15;111(12):1708-13. doi: 10.1016/j.amjcard.2013.02.023. Epub 2013 Mar 20.

PMID:
23523063
12.

[Acute myocardial infarction with persistent ST segment elevation: towards an appropriate diagnostic and therapeutic approach in the health care community].

Tavazzi L, Chiariello M, Scherillo M, Ferrari R, Greco C, Zardini P, Antoniucci D, Borsotti A, Crea F, Hugmann; [Italian Federation of Cardiology--National Association of Hospital Cardiologists, Italian Society of Cardiology].

Ital Heart J Suppl. 2002 Nov;3(11):1127-64. Italian. No abstract available.

PMID:
12506516
13.

Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction.

Greenberg G, Assali A, Vaknin-Assa H, Brosh D, Teplitsky I, Fuchs S, Battler A, Kornowski R, Lev EI.

Am J Cardiol. 2010 Feb 15;105(4):435-40. doi: 10.1016/j.amjcard.2009.10.016. Epub 2010 Jan 5.

PMID:
20152235
14.

Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.

Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.

Kardiol Pol. 2007 Jan;65(1):1-10; discussion 11-2. English, Polish.

15.

Repolarization parameters in patients with acute ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention with respect to predischarge ST-T pattern: a preliminary study.

Szydło K, Wita K, Trusz-Gluza M, Zawada K, Piecuch A, Kulach A, Kucz E, Tyrka A, Kornacka I, Trams-Stawowska P, Pieda G.

Cardiol J. 2009;16(1):52-6.

16.

[Value of ST-segment elevation resolution after primary coronary angioplasty in predicting early and late left ventricular function in patients with anterior acute myocardial infarction].

Araszkiewicz A, Lesiak M, Grajek S, Mularek-Kubzdela T, Popiel M, Cieśliński A.

Pol Merkur Lekarski. 2005 Jul;19(109):16-9. Polish.

PMID:
16194019
17.

Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).

Gierlotka M, Gasior M, Wilczek K, Hawranek M, Szkodzinski J, Paczek P, Lekston A, Kalarus Z, Zembala M, Polonski L.

Am J Cardiol. 2011 Feb 15;107(4):501-8. doi: 10.1016/j.amjcard.2010.10.008. Epub 2010 Dec 31.

PMID:
21195380
18.

[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation].

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M; Task Force per il Trattamento dell'Infarto Miocardico Acuto con; Sopraslivellamento del Tratto ST della Società Europea di Cardiologia, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F, Societá Europea di Cardiologia.

G Ital Cardiol (Rome). 2009 Jul;10(7):450-89. Italian. No abstract available.

PMID:
19761103
19.

Prehospital identification of acute coronary syndrome/myocardial infarction in relation to ST elevation.

Svensson L, Axelsson C, Nordlander R, Herlitz J.

Int J Cardiol. 2005 Feb 15;98(2):237-44.

PMID:
15686773
20.

Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.

McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, Grines CL, Tcheng JE, Cox DA, Stuckey T, Garcia E, Guagliumi G, Turco M, Josephson ME, Zimetbaum P; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial.

J Am Coll Cardiol. 2004 Sep 15;44(6):1215-23.

Supplemental Content

Support Center